Joe Rabin, Editor

About the Author Joe Rabin, Editor

Joe is an intern at Smarter Analyst. He has written on a broad range of topics, including: financial trading, career development, cybersecurity, gamification, network access control, recreation and more.

Things Are Looking Bullish Ahead of 2Q Print for Apple Inc. (AAPL), Facebook Inc (FB), and Alphabet Inc (GOOGL)

Apple Set for Strong Fiscal 2018 Despite Initial Shipment Delays As Apple Inc. (NASDAQ:AAPL) readies to release its third quarter earnings on August …

Here’s Why Analysts Are Sidelined on 2 Tech Kings Despite Price Target Lifts: Microsoft Corporation (MSFT) and QUALCOMM, Inc. (QCOM)

Microsoft Delivers Impressive FQ4 Earnings- But Needs More Tricks Up Its Sleeves Upon releasing fiscal fourth quarter results, Microsoft Corporation (NASDAQ:MSFT) shares jumped …

Check Point Software Technologies Ltd. (CHKP) to Rebound from Minor Setback, T-Mobile US Inc (TMUS) Set to Capture More Market Share

High Holy Day Is a Low Point for Check Point Co-founder and CEO of Check Point Software Technologies Ltd. (NASDAQ:CHKP) Gil Shwed is blaming an …

Analysts Tackle Online Giants: Netflix Inc. (NFLX), Snap Inc (SNAP), Facebook Inc (FB)

Expanding International Markets is Key to Spurring Netflix Growth Netflix, Inc. (NASDAQ:NFLX) stock rose significantly throughout 2Q in response to a dramatic increase …

Rodman and Renshaw Sings the Praises of Capricor Therapeutics, Inc. (CAPR); Here’s Why

On Tuesday, Capricor Therapeutics, Inc. (NASDAQ:CAPR) was granted FDA Rare Pediatric Disease Designation for CAP-1002, the company’s treatment for Duchenne muscular dystrophy (DMD) and …

Himax Technologies, Inc. (ADR) (HIMX) Fires Back at Oppenheimer

In an email to Smarter Analyst, Luke Zimmerman, Investor Relations Associate of MZ North America for Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) revealed the …

Oppenheimer Bullish on Bank of America Corp (BAC), CymaBay Therapeutics Inc (CBAY) and TherapeuticsMD Inc (TXMD); Here’s Why

Bank of America: Net Interest Income is Only Half the Story Bank of America Corp (NYSE:BAC) delivered better-than-expected second-quarter results, posting EPS of $0.46 compared …

Puma Biotechnology Inc (PBYI) Drug Nerlynx Set To Hit The Market; J.P. Morgan Chimes In

Puma Biotechnology Inc (NASDAQ:PBYI) has won FDA approval for its lead candidate Nerlynx (neratinib), sending shares up 9% in Tuesday’s trading session. The drug …

Amazon.com, Inc. (AMZN) Set to Eat Up the Food Industry

On July 12, 2017, RBC Capital held a symposium to assess the short and long-term impact Amazon.com, Inc.

Oppenheimer’s Take on Himax Technologies, Inc. (ADR) (HIMX), JPMorgan Chase & Co. (JPM) and Cyberark Software Ltd (CYBR)

Himax Technologies Falling Behind Competitors While hopes were high that 3D sensing could lift Himax Technologies, Inc. (ADR) (NASDAQ:HIMX), it is becoming clear …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts